Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CPT

16. Specific lobbying issues

CPT: Senate, House, Department of Commerce, Patent & Trademark Office, Department of Health and Human Services, Centers for Medicare and Medicaid Services, White House Executive Office of the President, Office of Science and Technology Policy

S. 708/H.R. 1574 (RESTORE Patent Rights Act)
S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act)
S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA))
S. 1367/H.R. 2794 (NO FAKES Act)
S. 1041 (Affordable Prescriptions for Patients Act)
S. 1097 (Interagency Patent Coordination and Improvement Act)
Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048)
Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods
Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee
America First Trade Policy section (3)(e) China intellectual property policies
Abuse of section 1498, as requested by Knowledge Ecology International (KEI) of the Department of Health and Human Services (HHS), as drug price controls to expropriate pharma patent rights
Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the
repudiated compelling merits standard for PTAB institution
Proposed violation of the Bayh-Dole Act by the government taking a share of the patent licensing royalties of universities patented inventions
United Kingdom (UK) Intellectual Property Office (IPO) proposal of a government-run licensing fee-setting scheme for standard-essential patents
U.S. Patent and Trademark Office Notice of Proposed Rulemaking (NPRM) to improve the Patent Trial and Appeal Boards (PTAB) practices for
instituting inter partes review (IPR) challenges (Docket No. PTO-P-2025-0025)
Office of Science and Technology Policy (OSTP) Notice of Request for Information (RFI) on Accelerating the American Scientific Enterprise (Docket No. OSTP-TECH-2025-0100)
H.R. 791 (Foreign Anti-Digital Piracy Act)
S. 2276/H.R. 3269 (Eliminating Thickets to Improve Competition (ETHIC) Act)
H.R. 5811 (Restoring Americas Leadership in Innovation Act (RALIA))
H.R. 1833 (Leadership in Critical and Emerging Technologies (CET) Act)
H.R. 861/S. 326 (American Music Fairness Act)

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Commerce - Dept of (DOC), Patent & Trademark Office (PTO), Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Office of Science & Technology Policy (OSTP)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act)
S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act)
Pharmacy benefits management reform
Inflation Reduction Act drug price negotiation
H.R. 1 (One Big Beautiful Bill Act) provisions related to proposed government drug price controls known as most favored nation being added to the Medicaid or any program
H.R. 1 (One Big Beautiful Bill Act) provisions related to Health Savings Account
(HSA) reforms
Centers for Medicare & Medicaid Services (CMS) Request for Comments on Medicare Drug Price Negotiation Program Draft Guidance, FR Doc. 2025-0860
Reform and eliminate fraud and abuse of the 340B program for pharmaceutical access by providers of indigent care
Allowing the Biden-COVID-era Obamacare premium support credits to expire
Centers for Medicare & Medicaid Services (CMS) proposed rules, Global Benchmark forEfficient Drug Pricing (GLOBE) for drugs covered under Medicare Part B (Docket No. CMS-2025-1889-0001) and Guarding U.S. Medicare Against Rising Drug Costs (GUARD) for drugs covered under Medicare Part D (Docket No. CMS-2025-1888-0001)
Elimination of the Center for Medicare and Medicaid Innovation (CMMI)
Approval of reauthorization of Floridas Medicaid hospital-directed payment program (DPP)
S. 3315 (Health Care Cybersecurity & Resiliency Act) regarding Sen. Bernie Sanderss amendments to codify Most Favored Nation drug price controls

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code LBR

16. Specific lobbying issues

H.R. 384 (One Agency Act)
S. 1040 (Drug Competition Enhancement Act)
S. 1096 (Preserve Access to Affordable Generics and Biosimilars Act)
S. 527 (Prescription Pricing for the People Act)
Seeking ways to lower prescription drug prices by promoting competition without expropriating patent rights

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

S. 587/H.R. 1301 (Death Tax Repeal Act)
Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions
H.R. 2230 (Independent Programmers Tax Incentive Act)
H.R. 1 (One Big Beautiful Bill Act), provisions related to permanent death tax relief
Proposed 1%-5% wealth or success tax on the value of commercialized U.S. patents
H.R. 1340/S. 3332 (More Homes on the Market Act) to adjust the home sale capital gains exclusion for inflation
H.R. 7687 (No Tax on Takings Act)

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Commerce - Dept of (DOC), Patent & Trademark Office (PTO)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code GOV

16. Specific lobbying issues

Executive Order 14192, Unleashing Prosperity Through Deregulation
H. Res. 294 provisions related to proxy voting
Government shutdown

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Executive Office of the President (EOP)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TRD

16. Specific lobbying issues

Special 301 Report - bolstering U.S. advocacy abroad for respecting intellectual property rights
U.S. Trade Representative Request for Comments Regarding Foreign Nations Freeloading on American-Financed Innovation (Docket No. USTR-2025-0011)
Employ robust trade policies and pressure tactics to cudgel foreign freeloaders to to stop using drug pricing disparities as a nontariff trade barrier and begin paying their fair share-actual market value-for U.S. medicines
U.S. Trade Representative Request for Comments on the Operation of the Agreement between the United States of America, the United Mexican States, and Canada (Docket No. USTR-2025-0004)
Urging pursuit in ongoing trade negotiations to ensure Japanese biopharma price controls do not thwart American medical innovation in global markets

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CAW

16. Specific lobbying issues

H.J. Res. 88, revoking pursuant to the Congressional Review Act California waivers from the Clean Air Act
Reform of the definition of the Waters of the United States (WOTUS) under the Clean Water Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Small Business Administration (SBA), Environmental Protection Agency (EPA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Republican Study Committee FY26 budget proposal

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HOU

16. Specific lobbying issues

Fannie Mae and Freddie Mac updates permitting mortgage lenders to choose between the current credit score and a new credit score model (Docket No. 2018-27565)

17. House(s) of Congress and Federal agencies Check if None

Federal Housing Finance Agency (FHFA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code RES

16. Specific lobbying issues

H.J. Res. 140 (Congressional Review Act disapproval of Public Land Order (PLO) 7917) issued by the Biden Administration to withdraw more than 225,000 acres of the Superior National Forest from mineral development for 20 years

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ENG

16. Specific lobbying issues

Suggesting reforms to adjust cost caps and include certain infrastructure under the Blanket Certificate Program

17. House(s) of Congress and Federal agencies Check if None

Federal Energy Regulatory Commission (FERC)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes